Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Scott Berkowitz

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rivaroxaban
115
2026
267
10.750
 Why?
Factor Xa Inhibitors
74
2026
187
5.830
 Why?
Aspirin
52
2026
400
4.490
 Why?
Anticoagulants
78
2024
724
4.380
 Why?
Stroke
69
2024
1258
4.110
 Why?
Peripheral Arterial Disease
32
2026
503
3.670
 Why?
Platelet Aggregation Inhibitors
51
2026
497
3.630
 Why?
Warfarin
42
2024
170
3.520
 Why?
Atrial Fibrillation
44
2024
550
3.290
 Why?
Hemorrhage
63
2026
809
2.870
 Why?
Intracranial Embolism
17
2021
34
2.340
 Why?
Morpholines
28
2024
129
2.250
 Why?
Thiophenes
27
2024
128
2.220
 Why?
Venous Thromboembolism
16
2022
324
2.050
 Why?
Embolism
17
2021
48
1.590
 Why?
Lower Extremity
16
2026
438
1.460
 Why?
Double-Blind Method
64
2026
2029
1.430
 Why?
Risk Adjustment
3
2020
85
1.390
 Why?
Arthroplasty, Replacement, Hip
9
2020
184
1.370
 Why?
Drug Monitoring
7
2021
395
1.270
 Why?
Endovascular Procedures
7
2026
384
1.190
 Why?
Myocardial Infarction
21
2024
1209
1.140
 Why?
Vitamin K
15
2017
45
1.050
 Why?
Drug Therapy, Combination
33
2026
1048
1.010
 Why?
Coronary Artery Disease
10
2024
741
0.970
 Why?
Arthroplasty, Replacement, Knee
13
2020
372
0.920
 Why?
Fibrinolytic Agents
11
2025
292
0.910
 Why?
Thrombosis
4
2022
393
0.890
 Why?
Aged
116
2026
25947
0.890
 Why?
Brain Ischemia
9
2022
358
0.880
 Why?
Treatment Outcome
76
2026
11695
0.880
 Why?
Enoxaparin
13
2020
67
0.820
 Why?
Heparin
15
2003
244
0.790
 Why?
Thromboembolism
8
2020
125
0.760
 Why?
Coronary Disease
12
2021
386
0.750
 Why?
Venous Thrombosis
12
2020
195
0.720
 Why?
Vascular Surgical Procedures
6
2026
340
0.690
 Why?
Thrombolytic Therapy
7
2017
163
0.690
 Why?
Brain Infarction
5
2021
23
0.680
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
9
2002
26
0.640
 Why?
Middle Aged
88
2026
35928
0.630
 Why?
Postoperative Complications
8
2024
2920
0.620
 Why?
Thrombocytopenia
11
2003
205
0.620
 Why?
Male
122
2026
72406
0.600
 Why?
Humans
176
2026
144957
0.600
 Why?
Ischemia
8
2024
421
0.580
 Why?
Female
119
2026
78376
0.560
 Why?
Administration, Oral
25
2021
848
0.540
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
257
0.530
 Why?
Risk Assessment
19
2024
3676
0.510
 Why?
Risk Factors
41
2026
10792
0.500
 Why?
Blood Coagulation
9
2020
268
0.490
 Why?
Angioplasty, Balloon, Coronary
8
2003
158
0.460
 Why?
Cardiovascular Diseases
9
2021
2171
0.440
 Why?
Immunoglobulin Fab Fragments
7
2002
56
0.430
 Why?
Prothrombin Time
5
2020
33
0.430
 Why?
Pulmonary Embolism
9
2020
244
0.420
 Why?
Dose-Response Relationship, Drug
18
2021
2032
0.410
 Why?
Blood Transfusion
4
2014
405
0.410
 Why?
Drug Administration Schedule
16
2021
783
0.370
 Why?
Biomarkers, Pharmacological
3
2020
26
0.360
 Why?
Secondary Prevention
8
2025
255
0.350
 Why?
Cerebral Hemorrhage
3
2021
120
0.340
 Why?
Aged, 80 and over
25
2026
8279
0.330
 Why?
Surgical Wound Infection
1
2014
316
0.330
 Why?
Azetidines
6
2005
45
0.300
 Why?
Angina, Unstable
5
2003
82
0.300
 Why?
Recurrence
11
2021
1135
0.290
 Why?
Plaque, Atherosclerotic
2
2020
60
0.290
 Why?
Heart Valve Prosthesis Implantation
2
2001
197
0.280
 Why?
Antibodies, Monoclonal
9
2002
1524
0.270
 Why?
Time Factors
18
2026
7183
0.270
 Why?
Randomized Controlled Trials as Topic
13
2024
1721
0.270
 Why?
Models, Statistical
3
2020
682
0.260
 Why?
Prognosis
6
2021
4293
0.250
 Why?
Vascular Diseases
2
2021
251
0.250
 Why?
Incidence
11
2021
2883
0.240
 Why?
Gastrointestinal Hemorrhage
2
2019
136
0.240
 Why?
Platelet Aggregation
3
2002
105
0.230
 Why?
Atherosclerosis
2
2019
409
0.230
 Why?
Kaplan-Meier Estimate
9
2021
966
0.230
 Why?
Aortic Valve Insufficiency
2
2016
43
0.220
 Why?
Mitral Valve Insufficiency
2
2016
72
0.210
 Why?
Follow-Up Studies
14
2020
5417
0.210
 Why?
International Normalized Ratio
5
2018
49
0.210
 Why?
Diabetes Mellitus
5
2021
1098
0.210
 Why?
Internationality
6
2021
156
0.200
 Why?
Proportional Hazards Models
9
2021
1325
0.200
 Why?
von Willebrand Factor
5
1993
85
0.200
 Why?
Anti-Arrhythmia Agents
2
2015
142
0.200
 Why?
Arteries
2
2022
259
0.200
 Why?
Intention to Treat Analysis
7
2021
80
0.200
 Why?
Chemoprevention
2
2020
90
0.190
 Why?
Antifibrinolytic Agents
2
2014
62
0.190
 Why?
Platelet Function Tests
2
2002
34
0.190
 Why?
Myocardial Ischemia
3
2000
285
0.190
 Why?
Postoperative Care
2
2003
288
0.190
 Why?
Acute Coronary Syndrome
2
2019
293
0.190
 Why?
Withholding Treatment
2
2021
81
0.190
 Why?
Drug Carriers
1
2003
130
0.180
 Why?
Renal Insufficiency
2
2021
169
0.180
 Why?
Electrocardiography
4
2001
663
0.180
 Why?
Carotid Artery Diseases
2
2019
69
0.180
 Why?
Echocardiography, Transesophageal
2
2019
133
0.180
 Why?
Multimorbidity
1
2022
63
0.180
 Why?
Drug-Eluting Stents
1
2021
88
0.170
 Why?
Heart Valves
1
2001
43
0.170
 Why?
Drug Substitution
3
2021
63
0.170
 Why?
Therapeutic Index
1
2020
3
0.160
 Why?
Intracranial Arteriosclerosis
1
2020
8
0.160
 Why?
Paclitaxel
1
2021
256
0.160
 Why?
Troponin T
1
2020
65
0.160
 Why?
Clinical Trials as Topic
6
2016
1054
0.160
 Why?
Thrombin
4
2014
166
0.160
 Why?
Intracranial Hemorrhages
4
2019
100
0.150
 Why?
Clinical Trials, Phase III as Topic
5
2019
117
0.150
 Why?
Thrombophlebitis
2
1997
12
0.150
 Why?
Tyrosine
1
2000
222
0.150
 Why?
Partial Thromboplastin Time
5
2014
50
0.150
 Why?
Comorbidity
6
2021
1660
0.140
 Why?
Point-of-Care Systems
2
2014
187
0.140
 Why?
Foramen Ovale, Patent
1
2018
11
0.140
 Why?
Kidney
2
2017
1496
0.140
 Why?
Emigrants and Immigrants
1
2021
158
0.140
 Why?
Cardiomegaly
1
2020
174
0.140
 Why?
Peptide Fragments
5
2003
699
0.140
 Why?
Ischemic Attack, Transient
2
2018
71
0.140
 Why?
Coronary Thrombosis
3
2016
25
0.140
 Why?
Polypharmacy
2
2016
93
0.140
 Why?
Antigens
1
1999
347
0.130
 Why?
Heart Diseases
1
2021
350
0.130
 Why?
Heart Failure
6
2021
2323
0.130
 Why?
Prospective Studies
12
2021
7997
0.130
 Why?
Brain
2
2020
2941
0.130
 Why?
Aorta, Thoracic
1
2019
286
0.120
 Why?
Surgery, Oral
1
1996
7
0.120
 Why?
Orthodontic Appliances
1
1996
13
0.120
 Why?
Drug Discovery
2
2015
155
0.120
 Why?
Body Mass Index
3
2021
2438
0.120
 Why?
Calcium Channel Blockers
1
2017
165
0.120
 Why?
Prodrugs
4
2005
52
0.120
 Why?
Angioplasty, Balloon
1
1997
94
0.120
 Why?
Antibodies, Monoclonal, Humanized
2
2020
988
0.120
 Why?
Overweight
1
2021
609
0.120
 Why?
Cleft Lip
1
1996
72
0.120
 Why?
Prevalence
5
2021
2836
0.110
 Why?
Neoplasms
3
2020
2884
0.110
 Why?
Cleft Palate
1
1996
89
0.110
 Why?
Multivariate Analysis
6
2016
1540
0.110
 Why?
Digoxin
1
2015
27
0.110
 Why?
Limb Salvage
2
2026
70
0.110
 Why?
Factor X
1
2014
25
0.110
 Why?
Prothrombin
1
2014
25
0.110
 Why?
Factor VII
1
2014
25
0.110
 Why?
Cognitive Dysfunction
1
2020
464
0.110
 Why?
Factor IX
1
2014
51
0.110
 Why?
Severity of Illness Index
6
2021
2925
0.110
 Why?
Amiodarone
1
2014
31
0.100
 Why?
Blood Coagulation Factors
1
2014
55
0.100
 Why?
Cognition Disorders
1
2018
538
0.100
 Why?
Cardiovascular Agents
1
2015
164
0.100
 Why?
Defibrillators, Implantable
1
2017
382
0.100
 Why?
Biomarkers
3
2020
4275
0.100
 Why?
Recombinant Proteins
4
2015
1371
0.100
 Why?
Models, Biological
2
2019
1822
0.100
 Why?
Arthroplasty, Replacement, Ankle
1
2012
11
0.090
 Why?
Mortality
3
2021
376
0.090
 Why?
Hematoma
1
2013
59
0.090
 Why?
Adult
17
2020
40506
0.090
 Why?
Elective Surgical Procedures
1
2014
201
0.090
 Why?
Hirudins
2
2003
51
0.090
 Why?
Sex Factors
4
2021
2114
0.090
 Why?
von Willebrand Diseases
2
1990
28
0.090
 Why?
Survival Rate
5
2020
2092
0.090
 Why?
Heparin, Low-Molecular-Weight
2
2005
36
0.090
 Why?
Depression
1
2021
1559
0.090
 Why?
Delivery of Health Care, Integrated
1
2014
299
0.080
 Why?
Percutaneous Coronary Intervention
1
2016
543
0.080
 Why?
Continuity of Patient Care
1
2013
292
0.080
 Why?
Peptides
4
2002
998
0.080
 Why?
Acute Disease
6
2021
1031
0.080
 Why?
Latin America
2
2021
94
0.080
 Why?
Predictive Value of Tests
4
2021
2118
0.080
 Why?
Factor Xa
3
2015
35
0.080
 Why?
Age Factors
4
2018
3335
0.080
 Why?
Benzylamines
6
2005
43
0.080
 Why?
Retrospective Studies
10
2018
17101
0.080
 Why?
Quality of Life
1
2022
3192
0.080
 Why?
Chemical and Drug Induced Liver Injury
1
2011
139
0.070
 Why?
Obesity, Morbid
1
2013
281
0.070
 Why?
Tissue Plasminogen Activator
3
2022
244
0.070
 Why?
Mental Health Services
1
2014
474
0.070
 Why?
Single-Blind Method
2
2020
312
0.070
 Why?
Sialic Acids
1
1988
8
0.070
 Why?
Platelet Count
3
1998
96
0.070
 Why?
Multicenter Studies as Topic
3
2018
405
0.070
 Why?
Pancreatic Elastase
1
1988
55
0.070
 Why?
Hospitalization
2
2016
2434
0.070
 Why?
Calpain
1
1988
61
0.070
 Why?
Injections, Subcutaneous
4
2010
164
0.070
 Why?
Magnetic Resonance Imaging
4
2021
3869
0.070
 Why?
Peptide Hydrolases
1
1988
105
0.070
 Why?
Logistic Models
4
2021
2119
0.070
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2021
338
0.070
 Why?
Platelet Transfusion
2
1999
80
0.060
 Why?
Hypertension
1
2016
1264
0.060
 Why?
Obesity
1
2021
3082
0.060
 Why?
Drug Approval
2
2015
91
0.060
 Why?
United States Food and Drug Administration
2
2015
205
0.060
 Why?
International Cooperation
2
2018
198
0.060
 Why?
Magnetic Resonance Angiography
2
2019
251
0.060
 Why?
Chronic Disease
2
2025
1813
0.060
 Why?
Cohort Studies
3
2022
5965
0.060
 Why?
Infusions, Intravenous
2
1998
423
0.060
 Why?
Drug Combinations
2
2019
392
0.060
 Why?
Europe
2
2019
412
0.060
 Why?
Preoperative Care
2
2020
380
0.060
 Why?
Adolescent
8
2020
22453
0.060
 Why?
Combined Modality Therapy
2
2020
1268
0.060
 Why?
Purinergic P2Y Receptor Antagonists
2
2018
69
0.060
 Why?
Creatinine
2
2017
506
0.050
 Why?
Forecasting
2
2013
391
0.050
 Why?
Pharmacokinetics
1
2003
32
0.050
 Why?
Safety
3
2000
356
0.050
 Why?
Caprylates
1
2003
27
0.050
 Why?
Body Weight
2
1998
978
0.050
 Why?
Angiography
1
2024
208
0.050
 Why?
United States
5
2019
15988
0.050
 Why?
Cause of Death
2
2016
472
0.050
 Why?
Myocardial Revascularization
2
2000
85
0.050
 Why?
Child
5
2020
22657
0.050
 Why?
Numbers Needed To Treat
1
2021
7
0.040
 Why?
Mobility Limitation
1
2022
66
0.040
 Why?
Injections, Intravenous
2
2000
200
0.040
 Why?
Pipecolic Acids
1
2001
24
0.040
 Why?
Hirudin Therapy
1
2000
2
0.040
 Why?
Intermittent Claudication
1
2022
121
0.040
 Why?
Frailty
1
2024
198
0.040
 Why?
Antineoplastic Agents, Phytogenic
1
2021
177
0.040
 Why?
Infant
3
2020
10039
0.040
 Why?
Antithrombins
1
2000
70
0.040
 Why?
Patient Care
1
2021
118
0.040
 Why?
Streptokinase
2
1997
9
0.040
 Why?
Heart Valve Diseases
1
2001
151
0.040
 Why?
Patient Safety
2
2013
349
0.040
 Why?
Acetates
1
2000
80
0.040
 Why?
Child, Preschool
3
2020
11799
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
77
0.040
 Why?
Stents
2
2002
556
0.040
 Why?
Cerebral Angiography
1
2019
119
0.040
 Why?
Drug Dosage Calculations
1
2019
27
0.040
 Why?
Heart Atria
1
2020
144
0.040
 Why?
Monitoring, Physiologic
1
2001
289
0.040
 Why?
MEDLINE
1
2018
20
0.040
 Why?
Diagnostic Tests, Routine
1
2019
108
0.040
 Why?
Sex Distribution
2
2015
386
0.030
 Why?
Arginine
2
2015
262
0.030
 Why?
Antibody Formation
1
1999
294
0.030
 Why?
Disease-Free Survival
1
2020
769
0.030
 Why?
Placebos
1
1998
193
0.030
 Why?
Australia
1
2019
286
0.030
 Why?
Pyridones
1
2020
199
0.030
 Why?
Blood Pressure
2
2016
1769
0.030
 Why?
Dermatan Sulfate
1
1997
4
0.030
 Why?
Computed Tomography Angiography
1
2019
145
0.030
 Why?
Global Health
1
2021
401
0.030
 Why?
Alanine Transaminase
2
2011
151
0.030
 Why?
Catheters, Indwelling
1
1998
96
0.030
 Why?
Chondroitin Sulfates
1
1997
35
0.030
 Why?
Statistics, Nonparametric
1
2018
427
0.030
 Why?
Coronary Artery Bypass
1
2000
269
0.030
 Why?
Hemodilution
1
1997
11
0.030
 Why?
Diltiazem
1
2017
17
0.030
 Why?
Health Status Disparities
1
2021
321
0.030
 Why?
Blood Transfusion, Autologous
1
1997
19
0.030
 Why?
Ligands
1
1999
674
0.030
 Why?
Verapamil
1
2017
37
0.030
 Why?
Walking
1
2022
545
0.030
 Why?
Hip Prosthesis
1
1997
43
0.030
 Why?
Recombinant Fusion Proteins
1
2000
675
0.030
 Why?
Postoperative Period
2
2013
354
0.030
 Why?
Gingivoplasty
1
1996
1
0.030
 Why?
Alveoloplasty
1
1996
2
0.030
 Why?
Lip
1
1996
22
0.030
 Why?
Morbidity
1
2017
323
0.030
 Why?
Maxillofacial Development
1
1996
20
0.030
 Why?
Kidney Function Tests
1
2017
157
0.030
 Why?
Infant, Newborn
2
2020
6434
0.030
 Why?
Knee Prosthesis
1
1997
29
0.030
 Why?
Phlebography
2
2009
39
0.030
 Why?
Glomerular Filtration Rate
1
2020
760
0.030
 Why?
Survival Analysis
1
2000
1385
0.030
 Why?
China
1
2017
269
0.030
 Why?
Bone Transplantation
1
1996
87
0.030
 Why?
Pyrazoles
1
2020
510
0.030
 Why?
Thrombophilia
1
2016
88
0.030
 Why?
Geography
1
2016
203
0.030
 Why?
Cardiopulmonary Bypass
1
1997
221
0.030
 Why?
Federal Government
1
2015
23
0.030
 Why?
Clinical Decision-Making
1
2019
359
0.030
 Why?
Death, Sudden
1
2015
24
0.030
 Why?
Government Regulation
1
2015
38
0.030
 Why?
Depressive Disorder
1
2018
387
0.030
 Why?
Blood Platelets
1
1998
400
0.030
 Why?
Anxiety Disorders
1
2018
373
0.030
 Why?
Drug Industry
1
2015
49
0.030
 Why?
Baltimore
1
2014
71
0.030
 Why?
Communication
1
2021
967
0.030
 Why?
Healthy Volunteers
1
2014
215
0.030
 Why?
Area Under Curve
1
2014
331
0.020
 Why?
Congresses as Topic
1
2015
221
0.020
 Why?
Risk
1
2016
911
0.020
 Why?
Leukemia, Promyelocytic, Acute
1
1993
8
0.020
 Why?
North America
1
2014
310
0.020
 Why?
Animals
5
2013
38109
0.020
 Why?
Endopeptidases
1
1993
82
0.020
 Why?
Aortic Valve Stenosis
1
2016
253
0.020
 Why?
Hemarthrosis
1
2012
22
0.020
 Why?
Neurotransmitter Agents
1
2013
82
0.020
 Why?
Macromolecular Substances
2
1993
224
0.020
 Why?
Piperazines
1
2015
381
0.020
 Why?
Plasma
1
2014
225
0.020
 Why?
Comparative Effectiveness Research
1
2013
170
0.020
 Why?
Evidence-Based Medicine
1
2016
732
0.020
 Why?
Pancreatitis
1
1993
145
0.020
 Why?
Clinical Protocols
1
2013
282
0.020
 Why?
Algorithms
1
1999
1839
0.020
 Why?
Validation Studies as Topic
1
2011
23
0.020
 Why?
Acenocoumarol
1
2010
1
0.020
 Why?
Liver Function Tests
1
2011
106
0.020
 Why?
Heart Rate
1
2015
855
0.020
 Why?
Bilirubin
1
2011
97
0.020
 Why?
Liver Cirrhosis
1
1993
288
0.020
 Why?
Adverse Drug Reaction Reporting Systems
1
2011
81
0.020
 Why?
Alkaline Phosphatase
1
2011
145
0.020
 Why?
Drug Design
1
2011
173
0.020
 Why?
Syndrome
2
2002
380
0.020
 Why?
Patient Selection
1
2014
719
0.020
 Why?
Cognition
1
2018
1269
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2738
0.020
 Why?
Biomedical Research
1
2015
710
0.020
 Why?
Coronary Angiography
2
2001
323
0.020
 Why?
Amino Acid Sequence
2
1990
2157
0.020
 Why?
Molecular Targeted Therapy
1
2011
434
0.020
 Why?
Structure-Activity Relationship
1
1988
570
0.020
 Why?
Molecular Structure
1
1988
501
0.020
 Why?
Immunoblotting
3
1993
300
0.020
 Why?
Risk Reduction Behavior
1
2009
226
0.020
 Why?
Registries
1
2016
2385
0.020
 Why?
In Vitro Techniques
1
1988
1048
0.020
 Why?
Research Design
1
2013
1137
0.020
 Why?
Epitopes
1
1988
485
0.020
 Why?
Analysis of Variance
1
2009
1311
0.020
 Why?
Blotting, Western
1
1988
1187
0.010
 Why?
Leukemia, Myeloid, Acute
1
1993
683
0.010
 Why?
Models, Molecular
1
2011
1619
0.010
 Why?
Cross-Sectional Studies
1
2016
5872
0.010
 Why?
Sensitivity and Specificity
1
2009
1990
0.010
 Why?
Hemostatics
1
2003
61
0.010
 Why?
Random Allocation
1
2003
363
0.010
 Why?
Fibrinolysin
2
1993
19
0.010
 Why?
Mice
1
2000
18365
0.010
 Why?
Drug Resistance
1
2002
153
0.010
 Why?
Statistics as Topic
1
2002
284
0.010
 Why?
Purpura
1
2001
18
0.010
 Why?
Blood Coagulation Tests
1
2001
70
0.010
 Why?
Wound Healing
1
2003
351
0.010
 Why?
Angina Pectoris
1
2000
75
0.010
 Why?
Exanthema
1
2001
84
0.010
 Why?
Diarrhea
1
2001
192
0.010
 Why?
Confidence Intervals
1
2000
333
0.010
 Why?
Probability
1
2000
312
0.010
 Why?
Age Distribution
1
2000
403
0.010
 Why?
Equipment Design
1
2001
530
0.010
 Why?
Mutation
1
1990
4099
0.010
 Why?
Odds Ratio
1
2000
1077
0.010
 Why?
Young Adult
1
2014
14126
0.010
 Why?
Hematocrit
1
1997
108
0.010
 Why?
Sulfonamides
1
2001
581
0.010
 Why?
Pain
1
2001
782
0.010
 Why?
Health Care Costs
1
1998
427
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1993
331
0.010
 Why?
Disease Progression
1
2000
2852
0.010
 Why?
Ristocetin
1
1992
1
0.010
 Why?
Length of Stay
1
1998
1337
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
1992
24
0.010
 Why?
Reference Values
1
1993
798
0.010
 Why?
Oligonucleotide Probes
1
1990
50
0.010
 Why?
Polymerase Chain Reaction
1
1990
1054
0.000
 Why?
Base Sequence
1
1990
2191
0.000
 Why?
Amino Acids
1
1990
522
0.000
 Why?
Molecular Sequence Data
1
1990
2931
0.000
 Why?
DNA
1
1990
1464
0.000
 Why?
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)